PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Growthphenylephrine hydrochloride injection, solution
NDAINTRAVENOUSSOLUTION
Approved
May 2025
Lifecycle
Growth
Competitive Pressure
0/100
Data completeness
3/8 — Basic
PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE (phenylephrine hydrochloride injection, solution) by Dr. Reddy's Laboratories is adrenergic alpha1-agonists [moa]. First approved in 2025.
Drug data last refreshed 1h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Phenylephrine hydrochloride injection is an alpha-1 adrenergic agonist administered intravenously as a solution in 0.9% sodium chloride. It functions as a selective alpha-1 receptor agonist that increases peripheral vascular resistance and blood pressure. This product is indicated for acute hypotension management in clinical settings such as operating rooms, intensive care units, and emergency departments.
Growth17.9 years to LOE
Early-stage growth product with newly granted approval presents opportunity for team expansion in commercial and medical affairs as market penetration develops.
Mechanism of Action
Adrenergic alpha1-Agonists
Pharmacologic Class:
alpha-1 Adrenergic Agonist
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This newly approved acute care product offers entry or growth opportunities in hospital-focused pharmaceutical roles where vasopressor expertise and acute care relationships are valued. Dr. Reddy's portfolio expansion into IV acute therapies signals team-building in commercial and medical affairs functions.
Brand ManagerMedical Science Liaison
Worked on PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.